AstraZeneca is a global, science- led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in therapy areas: oncology, cardiovascular, renal and metabolism, and respiratory and immunology. In response to the coronavirus pandemic, the company is progressing its vaccine candidate, AZD1222, and its long-acting antibody combination, AZD7442, for the prevention and treatment of the virus, respectively. In the US alone, the company has more than 30 life-changing medicines available that help treat millions of patients each year. Astra-Zeneca’s North American commercial headquarters are based in Wilmington, Delaware, and one of its three global research and development centers is based in Gaithersburg, Maryland. In total, the company has R&D, manufacturing, and commercial locations in 11 states, Puerto Rico, and Washington DC, and employs about 13 000 people nationwide.
US states and territories we’re located in: California, Delaware, Indiana, Kentucky, Massachusetts, Maryland, North Carolina, New York, Ohio, Pennsylvania, and Texas; Puerto Rico and Washington DC
Company Website: astrazeneca-us.com
